--2025/Q1-- / 31.500M--
--2024/Q4-- / 8.843M--
Nov 12, 20242024/Q349.412M / 25.071M--
Aug 6, 20242024/Q2356.000K / 8.260M--
May 9, 20242024/Q1481.000K / 6.361M--
US Stock MarketDetailed Quotes
SGMO Sangamo Therapeutics
- 2.470
- +0.160+6.93%
Close Dec 20 16:00 ET
- 2.480
- +0.010+0.40%
Post 20:01 ET
515.36MMarket Cap-3.48P/E (TTM)
2.530High2.250Low13.73MVolume2.300Open2.310Pre Close33.64MTurnover6.73%Turnover RatioLossP/E (Static)208.65MShares3.17952wk High13.14P/B503.97MFloat Cap0.30452wk Low--Dividend TTM204.04MShs Float51.375Historical High--Div YieldTTM12.12%Amplitude0.291Historical Low2.449Avg Price1Lot Size
Sangamo Therapeutics Key Stats
Sangamo Therapeutics Q3 2024 Earnings Date
Currency：USDNov 12, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 25.07M | 49.41M | +24.34M |
| Beat Est. | +166.77% | +425.77% | +97.08% |
| EPS | -0.04 | 0.04 | +0.08 |
| Beat Est. | +93.24% | +106.78% | +200.25% |
Analyst Rating
Dec 21, 2024
Sangamo Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Sangamo Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Price
% Chg
No Data
